Regency Fincorp secures BSE approval to list 58.6 lakh shares
Regency Fincorp received BSE approval on July 8, 2026, to list 58,62,879 equity shares issued at a premium of ₹12 per share upon warrant conversion. Trading approval is contingent upon NSE clearance and depository confirmations, which must be submitted within seven working days to avoid penalties.

*this image is generated using AI for illustrative purposes only.
Regency Fincorp received approval from BSE Limited on July 8, 2026, to list 58,62,879 equity shares following the conversion of warrants allotted to non-promoter shareholders. The shares, with a face value of ₹10 each, were issued at a premium of ₹12 per share. This listing approval allows the company to proceed with the formal admission of these shares to the exchange, subject to final trading permissions.
The approval was communicated via BSE letter reference number LOD/PREF/GB/FIP/483/2026-27. The shares bear distinctive numbers ranging from 80171072 to 86033950. The conversion pertains to warrants issued on a preferential basis to the Non-Promoter and Public Category shareholders.
Conditions for Trading Approval
Trading in these shares will commence only after the company fulfills specific regulatory requirements. Regency Fincorp must submit the listing approval from the National Stock Exchange of India Ltd., if applicable, and confirmation letters from NSDL and CDSL regarding the crediting of shares to beneficiary accounts. Additionally, the company must provide confirmation regarding the lock-in of pre-preferential holdings if applicable.
Regulatory Compliance
The company is required to ensure compliance with Regulation 167 of the SEBI (ICDR) Regulations. Furthermore, if the change in shareholding exceeds two per cent of the total paid-up share capital, the company must file the shareholding pattern in XBRL mode under Regulation 31(1)(c) of the SEBI LODR Regulations, 2015.
Timeline and Penalties
Pursuant to Schedule XIX of ICDR Regulations and a SEBI circular dated June 21, 2023, Regency Fincorp must apply for trading approval within seven working days from the date of listing approval. Failure to comply with this timeline will result in penalties as specified by the market regulator.
| Detail | Description |
|---|---|
| Exchange | BSE Limited |
| Shares Approved | 58,62,879 Equity Shares |
| Face Value | ₹10 per share |
| Issue Premium | ₹12 per share |
| Allotment Category | Non-Promoter / Public Category |
| Approval Date | July 8, 2026 |
Historical Stock Returns for Regency Fincorp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.84% | +1.88% | +16.05% | +24.73% | +50.30% | +471.63% |
How will the influx of over 58 lakh new shares impact Regency Fincorp's earnings per share (EPS) and existing shareholder value?
What are the strategic reasons behind the non-promoters exercising their warrants, and does this signal confidence in the company's future growth?
Given the tight seven-day window for trading approval, are there any anticipated delays that could trigger regulatory penalties?































